top of page

Major League JDA

The Major League Joint Drug Agreement outlines the policies governing drug testing, prevention, and education for Major League players. Jointly negotiated by the MLBPA and Major League Baseball, the agreement is designed to protect the integrity of the game while prioritizing player health and fairness.

It sets clear standards for testing procedures, disciplinary measures, and ongoing efforts to promote a clean and competitive sport.

This resource can be downloaded as a PDF by clicking below.

Download Now
Related Media

Follow Us

  • X
  • Instagram
  • Facebook
  • Youtube
  • LinkedIn
MLBPA Placeholder.avif

144 Players Become XX(B) Free Agents

144 players were declared XX(B) free agents at the conclusion of the 2026 season. Additional Players may become XX(B) free agents after their options are resolved or pending option decisions in their Uniform Player Contracts. 

October 29, 2026

Read Full Story
MLBPA Placeholder.avif

Pete-Crow Armstrong, Chris Bassitt, and Former Player David ...

Pete Crow-Armstrong has been named overall Player of the Year and NL Outstanding Player, while Yordan Álvarez took home the AL Outstanding Player and Comeback Player of the Year awards in the 2026 Players Choice Awards voting.

October 28, 2026

Read Full Story
MLBPA Placeholder.avif

Finalists Announced for the 2026 Players Choice Awards

Yordan Álvarez, Pete Crow-Armstrong and Shohei Ohtani are the finalists for Player of the Year in balloting for the 2026 Players Choice Awards. The winner of this award and seven others will be announced the week of October 26.

October 14, 2026

Read Full Story

Latest Press Releases

Stay up to date with the latest announcements, initiatives, and official updates from the MLBPA.

MLBPA

MLBPA

MLBPA

MLBPA

Media Inquiries

For press inquiries, interview requests, or additional information about the MLBPA.

bottom of page